Glucagon-like peptide-1 levels and dipeptidyl peptidase-4 activity in type 2 diabetes


SENYIGIT A., Tabak O. , ORBANOGLU T., Karadag A., Ugurlu S., Uzun H. , ...More

CLINICAL AND INVESTIGATIVE MEDICINE, vol.40, 2017 (Journal Indexed in SCI) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 40 Issue: 5
  • Publication Date: 2017
  • Doi Number: 10.25011/cim.v40i5.28624
  • Title of Journal : CLINICAL AND INVESTIGATIVE MEDICINE

Abstract

Purpose: Hyperglycemia is the major risk factor for microvascular complications in type 2 diabetes mellitus (T2DM) patients. This randomized controlled clinical trial aimed to investigate T2DM patients with microvascular complications with regard to possible relations among serum clusterin (CLU), amylin, secreted frizzled-related protein-4 (SFRP-4), glucagon-like peptide-1 (GLP-1) and dipeptidyl peptidase-4 (DPP-4) activities.